COVID-19 in patients with diabetes: clinical course, metabolic status, inflammation, and coagulation disorder

DV Belikina, ES Malysheva, AV Petrov… - Современные …, 2020 - cyberleninka.ru
The aim of the investigation was to study the clinical course of COVID-19 in the presence of
diabetes mellitus (DM) and elucidate possible mechanisms of their mutual aggravation …

[HTML][HTML] COVID-19 presenting with diabetic ketoacidosis: a case series

RS Gorthi, G Kamel, S Dhindsa, RP Nayak - AACE Clinical Case Reports, 2021 - Elsevier
Objective Diabetes mellitus has been recognized as one of the comorbidities that predict the
severity of illness in patients infected with COVID-19. The characteristics of patients …

COVID-19 pandemisi ve diabetes mellitus

F Kutlutürk - Türkiye Diyabet ve Obezite Dergisi, 2020 - dergipark.org.tr
The COVID-19 pandemic, caused by SARS-CoV-2 of Coronaviruses types, is a highly
infectious disease caused by SARS-CoV-2, which first appeared in China. The presence of …

[PDF][PDF] Clinical characteristics and severity profile of COVID-19 patient with hypertension in Palu, Central Sulawesi

I Faustine, A Malik, R Andrajati… - Indones J …, 2021 - pdfs.semanticscholar.org
Until this year, coronavirus infection (COVID-19) is still an unsolved problem in Indonesia.
Apart from Java, other islands, including Sulawesi, were also severely affected. The very …

Readability of online COVID-19 health information and advice

K Bould, MJ Forshaw - … Journal of Health Promotion and Education, 2023 - Taylor & Francis
Readability is a systematic measure of ease, with which written information can be read and
understood. It can affect the reader's ability to access, comprehend, and utilize health …

The effect of underlying diabetes disease on clinical outcome and survival in patients with Covid-19: a propensity score matching study

F Ghadamgahi, L Tapak, S Bashirian, R Amiri… - Journal of Diabetes & …, 2021 - Springer
Purpose Coronavirus increases mortality rate in people with underlying disease. The
purpose of the present research was to compare the clinical outcomes in Covid-19 patients …

Diabetes and COVID-19: what 2 years of the pandemic has taught us

AP Stoian, P Kempler, T Stulnig, AA Rizvi… - … Syndrome and Related …, 2022 - liebertpub.com
As the world enters its third year of the COVID-19 pandemic, individuals with diabetes have
faced particular challenges from the virus. A deleterious bidirectional relationship exists …

Analysis of the lymphocyte count in type 2 diabetic patients with coronavirus disease (COVID-19): A retrospective study in a centralized treatment center

D Wu, S Gao - diabetes research and clinical practice, 2020 - Elsevier
Objective To investigate the characteristics of lymphocytes in type 2 diabetic patients with
coronavirus disease (COVID-19). Methods Patients with COVID-19 admitted to hospital in …

[HTML][HTML] SARS-CoV-2 and diabetes: A potential therapeutic effect of dipeptidyl peptidase 4 inhibitors in diabetic patients diagnosed with COVID-19

ZD Kifle, AE Woldeyohanin, CA Demeke - Metabolism open, 2021 - Elsevier
COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 and has become
an urgent economic and health challenge. Dipeptidyl peptidase 4 (DPP4), also mentioned …

[HTML][HTML] Evaluación de comorbilidades y pronóstico de la neumonía por COVID-19: revisión de la literatura

FK Llanos Tejada, WI Muñoz Taipe… - Horizonte Médico …, 2021 - scielo.org.pe
La infección por COVID-19 presenta una elevada mortalidad respecto a otros virus
respiratorios. En este artículo buscamos definir las comorbilidades que están asociadas a la …